Citation 44643

GOSTOMSKI,FE:. (1978). THE EFFECTS OF AMYGDALIN ON THE KREBS-2 CARCINOMA AND ADULT AND FETAL DUB(ICR) MICE.. 39()

Citation Details

Title	THE EFFECTS OF AMYGDALIN ON THE KREBS-2 CARCINOMA AND ADULT AND FETAL DUB(ICR) MICE.
Authors	GOSTOMSKI,FE:
Year	1978
Volume	39
Issue

Summary

Year: 1978

Journal: Unknown

Organisms and Their Experiments (1)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	TOXICITY ASSESSMENT(QUANTITATIVE)	PHARMACOLOGY OF COMPOUND - IN VIVO	AMYGDALIN	.
2	TOXICITY ASSESSMENT(QUANTITATIVE)	PHARMACOLOGY OF COMPOUND - IN VIVO	AMYGDALIN	.
3	TOXIC EFFECT(GENERAL)	PHARMACOLOGY OF COMPOUND - IN VIVO	AMYGDALIN	ACTIVE
4	DEATH	TOXICITY MARKER CODEEFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN VIVO	AMYGDALIN	ACTIVE
5	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	AMYGDALIN	INACTIVE
6	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	AMYGDALIN	INACTIVE
7	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	AMYGDALIN	INACTIVE
8	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	AMYGDALIN	INACTIVE
9	TERATOGENIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	AMYGDALIN	INACTIVE
10	TERATOGENIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	AMYGDALIN	INACTIVE
11	TERATOGENIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	AMYGDALIN	INACTIVE
12	TERATOGENIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	AMYGDALIN	INACTIVE

Show SPARQL Queries (1)